NCT05413460

Brief Summary

In this prospective randomized controlled trial, the subjects will be assigned to group transcutaneous electrical acupoint stimulation (TEAS) and group control (no intervention). The postoperative outcomes including NIHSS (National Institute of Health stroke scale) score, morbidity and mortality will be evaluated during hospital stay and by one year after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

July 26, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

December 6, 2022

Status Verified

December 1, 2022

Enrollment Period

11 months

First QC Date

May 25, 2022

Last Update Submit

December 2, 2022

Conditions

Keywords

transcutaneous electrical acupoint stimulationendovascular treatment

Outcome Measures

Primary Outcomes (1)

  • number of patients with major in-hospital postoperative complications

    major complications include myocardial infarction, heart failure, respiratory failure, mechanical ventilation, cerebral infarction, delirium and coma

    from end of surgery to discharge from hospital, in an average of 7 days

Secondary Outcomes (15)

  • mortality by 30 days after surgery

    from end of surgery to 30 days after surgery, in a total of 30 days

  • mortality by 3 months after surgery

    from end of surgery to 3 months after surgery, in a total of 3 months

  • number of patients with major postoperative complications by 3 months after surgery

    from end of surgery to 3 months after surgery, in a total of 3 months

  • mortality by 6 months after surgery

    from end of surgery to 6 months after surgery, in a total of 6 months

  • number of patients with major postoperative complications by 6 months after surgery

    from end of surgery to 6 months after surgery, in a total of 6 months

  • +10 more secondary outcomes

Study Arms (2)

transcutaneous electrical acupoint stimulation

EXPERIMENTAL

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given during surgery.

Device: transcutaneous electrical acupoint stimulation

Control

NO INTERVENTION

Electrodes are placed at acupoints and connected to the stimulator. But no stimulation is given during surgery.

Interventions

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given during surgery.

Also known as: TEAS
transcutaneous electrical acupoint stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years
  • patients scheduled for cranial endovascular treatment

You may not qualify if:

  • American Society of Anesthesiologists class Ⅲ or higher
  • Hunt-Hess class Ⅲ or higher
  • body mass index (BMI) \< 18 kg/㎡ or \> 30kg/㎡
  • large or giant cerebral aneurysms with diameters greater than 15mm and minor cerebral aneurysms with diameters less than 3mm
  • posterior circulation infarction
  • recurrence of an cerebral aneurysms after endovascular procedures or surgical clipping
  • severe abnormal coagulation function, severe liver and kidney function damage, or combined with heart and respiratory system failure
  • injury or infection of the skin around the acupoint area
  • participate in other clinical researchers within 3 months
  • history of neurological or psychiatric diseases
  • patients with implanted electrophysiological device
  • use of sedative or analgesics before surgery
  • patients with difficulty in communication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing hospital, Fourth military medical university

Xi'an, Shaanxi, 710032, China

RECRUITING

Related Publications (3)

  • Dhillon PS, Butt W, Podlasek A, McConachie N, Lenthall R, Nair S, Malik L, Hewson DW, Bhogal P, Makalanda HLD, James MA, Dineen RA, England TJ. Association between anesthesia modality and clinical outcomes following endovascular stroke treatment in the extended time window. J Neurointerv Surg. 2023 May;15(5):478-482. doi: 10.1136/neurintsurg-2022-018846. Epub 2022 Apr 21.

    PMID: 35450928BACKGROUND
  • Campbell D, Deng C, McBryde F, Billing R, Diprose WK, Short TG, Frampton C, Brew S, Barber PA; MASTERSTROKE Study Group. Protocol for the MAnagement of Systolic blood pressure during Thrombectomy by Endovascular Route for acute ischemic STROKE randomized clinical trial: The MASTERSTROKE trial. Int J Stroke. 2022 Aug;17(7):810-814. doi: 10.1177/17474930211059029. Epub 2021 Nov 22.

    PMID: 34806930BACKGROUND
  • Samuels N, van de Graaf RA, van den Berg CAL, Uniken Venema SM, Bala K, van Doormaal PJ, van der Steen W, Witvoet E, Boiten J, den Hertog H, Schonewille WJ, Hofmeijer J, Schreuder F, Schreuder TAHCML, van der Worp HB, Roos YBWEM, Majoie CBLM, Burke JF, van Es ACGM, van der Lugt A, Roozenbeek B, Lingsma HF, Dippel DWJ; MR CLEAN Registry Investigators. Blood Pressure in the First 6 Hours Following Endovascular Treatment for Ischemic Stroke Is Associated With Outcome. Stroke. 2021 Nov;52(11):3514-3522. doi: 10.1161/STROKEAHA.120.033657. Epub 2021 Sep 20.

    PMID: 34538090BACKGROUND

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All participants are placed with electrodes at acupoints. The stimulator is put in an opaque box.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 25, 2022

First Posted

June 10, 2022

Study Start

July 26, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

December 6, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations